Selective Induction of Activated Regulatory T-Cells in Healthy Volunteers by NKTR-358, a Novel IL-2 Conjugate Treg Stimulator, in Development for the Treatment of Autoimmune Diseases Carlos Bonilla2022-08-08T17:05:53-04:00Resources| Read More
Etrolizumab Treatment Increases Blood Levels of CD3, Treg and Th17 Cells Measured Through Epigenetic Activation of CD3, FOXP3 and IL-17 Loci Carlos Bonilla2022-08-08T17:06:12-04:00Resources| Read More
The Impact of the Th17: Treg Axis on the IgA-Biome Across the Glycemic Spectrum Carlos Bonilla2022-08-08T17:07:18-04:00Resources| Read More
The Cellular Ratio of Immune Tolerance (immunoCRIT) Is a Definite Marker for Aggressiveness of Solid Tumors and May Explain Tumor Dissemination Patterns Carlos Bonilla2022-08-08T17:07:53-04:00Resources| Read More
Epigenetic Quantification of Tumor-Infiltrating T-Lymphocytes Carlos Bonilla2022-08-08T17:08:18-04:00Resources| Read More
Th17/Treg Ratio Derived Using DNA Methylationanalysis Is Associated With the Late Phase Asthmatic Response Carlos Bonilla2022-08-08T17:08:31-04:00Resources| Read More
In Vivo Maintenance of Human Regulatory T Cells During CD25 Blockade Carlos Bonilla2022-08-08T17:08:44-04:00Resources| Read More
Evidence of Target Engagement and Modulation: Biomarker Analysis of the Phase 1b Inhaled Seralutinib Study Carlos Bonilla2022-08-08T17:08:56-04:00Resources| Read More
Biological Impact of Iberdomide in Patients With Active Systemic Lupus Erythematosus Carlos Bonilla2022-08-19T16:19:48-04:00Resources| Read More
Demethylation Analysis of the FOXP3 Locus Shows Quantitative Defects of Regulatory T Cells in IPEX-like Syndrome Carlos Bonilla2022-08-19T16:20:38-04:00Resources| Read More